{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:06:42Z","timestamp":1792595202618,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["VU-2018-11648"],"award-info":[{"award-number":["VU-2018-11648"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["VU-2018-11648"],"award-info":[{"award-number":["VU-2018-11648"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023452","name":"Hanarth Fonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Convolutional neural networks (CNNs) may improve response prediction in diffuse large B-cell lymphoma (DLBCL). The aim of this study was to investigate the feasibility of a CNN using maximum intensity projection (MIP) images from\n                    <jats:sup>18<\/jats:sup>\n                    F-fluorodeoxyglucose (\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG) positron emission tomography (PET) baseline scans to predict the probability of time-to-progression (TTP) within 2\u00a0years and compare it with the International Prognostic Index (IPI), i.e. a clinically used score. 296 DLBCL\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG PET\/CT baseline scans collected from a prospective clinical trial (HOVON-84) were analysed. Cross-validation was performed using coronal and sagittal MIPs. An external dataset (340 DLBCL patients) was used to validate the model. Association between the probabilities, metabolic tumour volume and Dmax\n                    <jats:sub>bulk<\/jats:sub>\n                    was assessed. Probabilities for PET scans with synthetically removed tumors were also assessed. The CNN provided a 2-year TTP prediction with an\u00a0area under the curve (AUC) of 0.74, outperforming the IPI-based model (AUC\u2009=\u20090.68). Furthermore, high probabilities (&gt;\u20090.6) of the original MIPs were considerably decreased after removing the tumours (&lt;\u20090.4, generally). These findings suggest that MIP-based CNNs are able to predict treatment outcome in DLBCL.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-40218-1","type":"journal-article","created":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T06:01:51Z","timestamp":1691820111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients"],"prefix":"10.1038","volume":"13","author":[{"given":"Maria C.","family":"Ferr\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep S. V.","family":"Golla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakoba J.","family":"Eertink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart M.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieternella J.","family":"Lugtenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne E.","family":"Wiegers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerben J. C.","family":"Zwezerijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Pieplenbosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Kurch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"H\u00fcttmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Hanoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"D\u00fchrsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrica C. W.","family":"de Vet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"PETRA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto S.","family":"Hoekstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coreline N.","family":"Burggraaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Bes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn W.","family":"Heymans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne W. S.","family":"Jauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine E. D.","family":"Chamuleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally F.","family":"Barrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Mikhaeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Zucca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Ceriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Gy\u00f6rke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e1ndor","family":"Czibor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lale","family":"Kostakoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Loft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hutchings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze Ting","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9e M.","family":"Zijlstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Boellaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,12]]},"reference":[{"key":"40218_CR1","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1182\/blood-2017-03-769620","volume":"130","author":"M Crump","year":"2017","unstructured":"Crump, M. et al. Outcomes in refractory diffuse large B-cell lymphoma: Results from the international scholar-1 study. Blood 130, 1800\u20131808 (2017).","journal-title":"Blood"},{"key":"40218_CR2","doi-asserted-by":"publisher","first-page":"117693511983553","DOI":"10.1177\/1176935119835538","volume":"18","author":"A Galaznik","year":"2019","unstructured":"Galaznik, A. et al. Predicting outcomes in patients with diffuse large B-cell lymphoma treated with standard of care. Cancer Inform. 18, 1176935119835538 (2019).","journal-title":"Cancer Inform."},{"key":"40218_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard, R. et al. FDG PET\/CT: EANM procedure guidelines for tumour imaging: Version 2.0. Eur. J. Nucl. Med. Mol. Imaging 42, 328\u2013354 (2015).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"40218_CR4","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1007\/s00259-021-05480-3","volume":"49","author":"JJ Eertink","year":"2022","unstructured":"Eertink, J. J. et al. (18)F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma. Eur. J. Nucl. Med. Mol. Imaging 49, 932\u2013942 (2022).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"40218_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2967\/jnumed.119.229450","volume":"61","author":"AS Cottereau","year":"2020","unstructured":"Cottereau, A. S. et al. (18)F-FDG PET dissemination features in diffuse large B-cell lymphoma are predictive of outcome. J. Nucl. Med. 61, 40\u201345 (2020).","journal-title":"J. Nucl. Med."},{"key":"40218_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejca.2019.09.027","volume":"124","author":"C Schmitz","year":"2020","unstructured":"Schmitz, C. et al. Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the petal trial. Eur. J. Cancer 124, 25\u201336 (2020).","journal-title":"Eur. J. Cancer"},{"key":"40218_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.compmedimag.2016.11.008","volume":"60","author":"L Bi","year":"2017","unstructured":"Bi, L. et al. Automatic detection and classification of regions of FDG uptake in whole-body PET-CT lymphoma studies. Comput. Med. Imaging Graph. 60, 3\u201310 (2017).","journal-title":"Comput. Med. Imaging Graph."},{"key":"40218_CR8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1148\/radiol.2019191114","volume":"294","author":"L Sibille","year":"2020","unstructured":"Sibille, L. et al. (18)F-FDF PET\/CT uptake classification in lymphoma and lung cancer by using deep convolutional neural networks. Radiology 294, 445\u2013452 (2020).","journal-title":"Radiology"},{"key":"40218_CR9","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1007\/s00259-020-05080-7","volume":"48","author":"P Blanc-Durand","year":"2021","unstructured":"Blanc-Durand, P. et al. Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG PET\/CT for total metabolic tumour volume prediction using a convolutional neural network. Eur. J. Nucl. Med. Mol. Imaging 48, 1362\u20131370 (2021).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"40218_CR10","doi-asserted-by":"publisher","first-page":"085019","DOI":"10.1088\/1361-6560\/ab0b64","volume":"64","author":"L Chen","year":"2019","unstructured":"Chen, L. et al. Automatic pet cervical tumor segmentation by combining deep learning and anatomic prior. Phys. Med. Biol. 64, 085019 (2019).","journal-title":"Phys. Med. Biol."},{"key":"40218_CR11","doi-asserted-by":"crossref","unstructured":"Girum, K. B. et al. (18)F-FDG PET maximum intensity projections and artificial intelligence: A win-win combination to easily measure prognostic biomarkers in dlbcl patients. J. Nucl. Med. (2022).","DOI":"10.2967\/jnumed.121.263501"},{"key":"40218_CR12","doi-asserted-by":"publisher","first-page":"6322","DOI":"10.1007\/s00330-020-06982-8","volume":"30","author":"N Fujima","year":"2020","unstructured":"Fujima, N. et al. Deep learning analysis using FDG-PET to predict treatment outcome in patients with oral cavity squamous cell carcinoma. Eur. Radiol. 30, 6322\u20136330 (2020).","journal-title":"Eur. Radiol."},{"key":"40218_CR13","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1007\/s00259-021-05232-3","volume":"48","author":"R Guo","year":"2021","unstructured":"Guo, R. et al. Weakly supervised deep learning for determining the prognostic value of (18)F-FDG PET\/CT in extranodal natural killer\/t cell lymphoma, nasal type. Eur. J. Nucl. Med. Mol. Imaging 48, 3151\u20133161 (2021).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"40218_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/BF03164863","volume":"13","author":"MM Takehiko Fujiwara","year":"1999","unstructured":"Takehiko Fujiwara, M. M., Watanuki, S., Mejia, M. A. & Itoh, M. Hiroshi Fukuda Easy detection of tumor in oncologic whole-body PET by projection reconstruction images with maximum intensity projection algorithm. Ann. Nucl. Med. 13, 199\u2013203 (1999).","journal-title":"Ann. Nucl. Med."},{"key":"40218_CR15","first-page":"348","volume":"48","author":"R Boellaard","year":"2021","unstructured":"Boellaard, R. et al. Artificial Intelligence based outcome classification from baseline 18F-FDG PET\/CT in de novo diffuse large B-cell lymphoma patients. European association of nuclear medicine October 20\u201323, 2021 virtual. Eur. J. Nucl. Med. Mol. Imaging 48, 348 (2021).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"40218_CR16","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1200\/JCO.19.03418","volume":"38","author":"PJ Lugtenburg","year":"2020","unstructured":"Lugtenburg, P. J. et al. Rituximab-chop with early rituximab intensification for diffuse large B-cell lymphoma: A randomized phase III trial of the HOVON and the NORDIC lymphoma group (HOVON-84). J. Clin. Oncol. 38, 3377\u20133387 (2020).","journal-title":"J. Clin. Oncol."},{"key":"40218_CR17","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1200\/JCO.2017.76.8093","volume":"36","author":"U Duhrsen","year":"2018","unstructured":"Duhrsen, U. et al. Positron emission tomography-guided therapy of aggressive non-hodgkin lymphomas (PETAL): A multicenter, randomized phase III trial. J. Clin. Oncol. 36, 2024\u20132034 (2018).","journal-title":"J. Clin. Oncol."},{"key":"40218_CR18","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/bloodadvances.2021004467","volume":"5","author":"JJ Eertink","year":"2021","unstructured":"Eertink, J. J. et al. Optimal timing and criteria of interim pet in DLBCL: A comparative study of 1692 patients. Blood Adv. 5, 2375\u20132384 (2021).","journal-title":"Blood Adv."},{"key":"40218_CR19","first-page":"3055","volume":"141","author":"JJ Eertink","year":"2023","unstructured":"Eertink, J. J. et al. Baseline pet radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma. Blood 141, 3055\u20133064 (2023).","journal-title":"Blood"},{"key":"40218_CR20","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2967\/jnumed.118.211607","volume":"59","author":"R Boellaard","year":"2018","unstructured":"Boellaard, R. Quantitative oncology molecular analysis suite: Accurate. J. Nucl. Med. 59, 1753 (2018).","journal-title":"J. Nucl. Med."},{"key":"40218_CR21","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2967\/jnumed.119.238923","volume":"62","author":"SF Barrington","year":"2021","unstructured":"Barrington, S. F. et al. Automated segmentation of baseline metabolic total tumor burden in diffuse large B-cell lymphoma: Which method is most successful? A study on behalf of the PETRA consortium. J. Nucl. Med. 62, 332\u2013337 (2021).","journal-title":"J. Nucl. Med."},{"key":"40218_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1109\/TSMC.1979.4310076","volume":"9","author":"N Otsu","year":"1979","unstructured":"Otsu, N. A threshold selection method from gray-level histograms. IEEE Trans. Syst. Man Cybern. 9, 62\u201366 (1979).","journal-title":"IEEE Trans. Syst. Man Cybern."},{"key":"40218_CR23","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1200\/JCO.21.02063","volume":"40","author":"NG Mikhaeel","year":"2022","unstructured":"Mikhaeel, N. G. et al. Proposed new dynamic prognostic index for diffuse large B-cell lymphoma: International metabolic prognostic index. J Clin. Oncol. 40, 2352\u20132360 (2022).","journal-title":"J Clin. Oncol."},{"key":"40218_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13550-022-00931-w","volume":"12","author":"JJ Eertink","year":"2022","unstructured":"Eertink, J. J. et al. External validation: A simulation study to compare cross-validation versus holdout or external testing to assess the performance of clinical prediction models using pet data from DLBCL patients. EJNMMI Res. 12, 58 (2022).","journal-title":"EJNMMI Res."},{"key":"40218_CR25","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1001\/jama.1983.03340110071044","volume":"250","author":"PS Levy","year":"1983","unstructured":"Levy, P. S. Clinical epidemiology: The essentials. JAMA 250, 1469\u20131469 (1983).","journal-title":"JAMA"},{"key":"40218_CR26","doi-asserted-by":"crossref","unstructured":"Delong, E. R., Delong, D. M., & Clarke-Pearson, D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics, 837\u2013845 (1988).","DOI":"10.2307\/2531595"},{"key":"40218_CR27","doi-asserted-by":"publisher","first-page":"102410","DOI":"10.1016\/j.ctrv.2022.102410","volume":"108","author":"C Corti","year":"2022","unstructured":"Corti, C. et al. Artificial intelligence for prediction of treatment outcomes in breast cancer: Systematic review of design, reporting standards, and bias. Cancer Treat. Rev. 108, 102410 (2022).","journal-title":"Cancer Treat. Rev."},{"key":"40218_CR28","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1007\/s00259-021-05233-2","volume":"48","author":"R Frood","year":"2021","unstructured":"Frood, R. et al. Baseline PET\/CT imaging parameters for prediction of treatment outcome in hodgkin and diffuse large B cell lymphoma: A systematic review. Eur. J. Nucl. Med. Mol. Imaging 48, 3198\u20133220 (2021).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"40218_CR29","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.2967\/jnumed.121.263239","volume":"63","author":"AK Jha","year":"2022","unstructured":"Jha, A. K. et al. Nuclear medicine and artificial intelligence: Best practices for evaluation (the RELIANCE guidelines). J. Nucl. Med. 63, 1288\u20131299 (2022).","journal-title":"J. Nucl. Med."},{"key":"40218_CR30","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1182\/blood.2022015789","volume":"139","author":"J Westin","year":"2022","unstructured":"Westin, J. & Sehn, L. H. CAR T cells as a second-line therapy for large B-cell lymphoma: A paradigm shift?. Blood 139, 2737\u20132746 (2022).","journal-title":"Blood"},{"key":"40218_CR31","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1007\/s00330-020-06815-8","volume":"30","author":"N Aide","year":"2020","unstructured":"Aide, N., Fruchart, C., Nganoa, C., Gac, A. C. & Lasnon, C. Baseline (18)F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy. Eur. Radiol. 30, 4623\u20134632 (2020).","journal-title":"Eur. Radiol."},{"key":"40218_CR32","doi-asserted-by":"publisher","first-page":"153601211986353","DOI":"10.1177\/1536012119863531","volume":"18","author":"R Zhang","year":"2019","unstructured":"Zhang, R., Cheng, C., Zhao, X. & Li, X. Multiscale mask R-CNN-based lung tumor detection using PET imaging. Mol. Imaging 18, 1536012119863531 (2019).","journal-title":"Mol. Imaging"},{"key":"40218_CR33","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/jha2.421","volume":"3","author":"L Kostakoglu","year":"2022","unstructured":"Kostakoglu, L. et al. A prognostic model integrating PET-derived metrics and image texture analyses with clinical risk factors from GOYA. EJHaem 3, 406\u2013414 (2022).","journal-title":"EJHaem"},{"key":"40218_CR34","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/bjh.16875","volume":"192","author":"NG Mikhaeel","year":"2021","unstructured":"Mikhaeel, N. G. et al. FDG PET\/CT after two cycles of R-CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome: Final result of a UK national cancer research institute prospective study. Br. J. Haematol. 192, 504\u2013513 (2021).","journal-title":"Br. J. Haematol."},{"key":"40218_CR35","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.annonc.2020.11.019","volume":"32","author":"AS Cottereau","year":"2021","unstructured":"Cottereau, A. S. et al. Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET\/CT(dagger). Ann. Oncol. 32, 404\u2013411 (2021).","journal-title":"Ann. Oncol."},{"key":"40218_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40644-022-00476-0","volume":"22","author":"S Jemaa","year":"2022","unstructured":"Jemaa, S. et al. Full automation of total metabolic tumor volume fromFDG PET\/CT in dlbcl for baseline risk assessments. Cancer Imaging 22, 39 (2022).","journal-title":"Cancer Imaging"},{"key":"40218_CR37","doi-asserted-by":"publisher","first-page":"e200016","DOI":"10.1148\/ryai.2020200016","volume":"2","author":"AJ Weisman","year":"2020","unstructured":"Weisman, A. J. et al. Convolutional neural networks for automated PET\/CT detection of diseased lymph node burden in patients with lymphoma. Radiol. Artif. Intell. 2, e200016 (2020).","journal-title":"Radiol. Artif. Intell."},{"key":"40218_CR38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s40658-020-00346-3","volume":"7","author":"AJ Weisman","year":"2020","unstructured":"Weisman, A. J. et al. Automated quantification of baseline imaging pet metrics on FDG PET\/CT images of pediatric hodgkin lymphoma patients. EJNMMI Phys. 7, 76 (2020).","journal-title":"EJNMMI Phys."},{"key":"40218_CR39","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1001\/jama.2018.17163","volume":"320","author":"EH Shortliffe","year":"2018","unstructured":"Shortliffe, E. H. & Sepulveda, M. J. Clinical decision support in the era of artificial intelligence. JAMA 320, 2199\u20132200 (2018).","journal-title":"JAMA"},{"key":"40218_CR40","doi-asserted-by":"publisher","first-page":"81612","DOI":"10.1109\/ACCESS.2022.3195906","volume":"10","author":"P Liu","year":"2022","unstructured":"Liu, P., Zhang, M., Gao, X., Li, B. & Zheng, G. Joint lymphoma lesion segmentation and prognosis prediction from baseline FDG PET images via multitask convolutional neural networks. IEEE Access 10, 81612\u201381623 (2022).","journal-title":"IEEE Access"},{"key":"40218_CR41","first-page":"3250","volume":"63","author":"L Rebaud","year":"2022","unstructured":"Rebaud, L. et al. Multitask learning-to-rank neural network for predicting survival of diffuse large b-cell lymphoma patients from their unsegmented baseline [18F]FDG PET\/CT scans. J. Nucl. Med. 63, 3250\u20133250 (2022).","journal-title":"J. Nucl. Med."},{"key":"40218_CR42","doi-asserted-by":"publisher","first-page":"e1004896","DOI":"10.1371\/journal.pcbi.1004896","volume":"12","author":"J Kubilius","year":"2016","unstructured":"Kubilius, J., Bracci, S. & Op de Beeck, H. P. Deep neural networks as a computational model for human shape sensitivity. PLoS Comput. Biol. 12, e1004896 (2016).","journal-title":"PLoS Comput. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40218-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40218-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40218-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T09:10:08Z","timestamp":1700212208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40218-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,12]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["40218"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-40218-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2761494\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,12]]},"assertion":[{"value":"31 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was financially supported by the Hanarth Fonds Fund and the Dutch Cancer Society (#VU-2018-11648). M.C.F., S.S.V.G, J.J.E., B.M.d.V., S.E.W., G.J.C.Z., S.P., L.K., A.H., C.H., U.D., H.C.W.d.V. and R.B. declare no competing financial interests. P.J.L. received research funding from Takeda, Servier and Roche and received honoraria for advisory boards from Takeda, Servier, Genentech, Genmab, Celgene, Incyte and AbbVie. J.M.Z. received research funding from Roche and received honoraria for advisory boards from Takeda, Gilead, BMS and Roche. No other potential conflicts of interest relevant to this article exist.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13111"}}